Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry

Head and Neck

Volumn 36, Issue 9, 2014, Pages 1356-1362

  Jackson, William ^a   Alexander, Neil ^a,b,c,d   Schipper, Matthew ^a   Fig, Lorraine ^d   Feng, Felix ^a   Jolly, Shruti ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

chemoradiotherapy; dual energy x ray absorptiometry (DEXA); head and neck cancer; lean body mass; total body composition

Indexed keywords

CREATININE;

ADULT; ARTICLE; BODY COMPOSITION; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT BODY; HEAD AND NECK CANCER; HUMAN; LEAN BODY WEIGHT; PRIORITY JOURNAL; WEIGHT REDUCTION; ADVERSE EFFECTS; BLOOD; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; FEMALE; HEAD AND NECK NEOPLASMS; KINESIOTHERAPY; MALE; METABOLISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY; QUALITY OF LIFE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ABSORPTIOMETRY, PHOTON; BODY COMPOSITION; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COHORT STUDIES; CREATININE; EXERCISE THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; WEIGHT LOSS;

EID: 84906085145     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23461     Document Type: Article

References (34)

1. Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 2012; 31: 74-77.
2. Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG,. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care-correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 2005; 103: 2189-2198.
3. Gil KM, Frasure HE, Hopkins MP, Jenison EL, von Gruenigen VE,. Body weight and composition changes in ovarian cancer patients during adjuvant chemotherapy. Gynecol Oncol 2006; 103: 247-252.
4. Harvie MN, Campbell IT, Thatcher N, Baildam A,. Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy. J Hum Nutr Diet 2003; 16: 323-326.
5. Jacquelin-Ravel N, Pichard C,. Clinical nutrition, body composition and oncology: a critical literature review of the synergies. Crit Rev Oncol Hematol 2012; 84: 37-46.
6. Silver HJ, Dietrich MS, Murphy BA,. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 2007; 29: 893-900.
7. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC,. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 6973-6979.
8. Smith MR,. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 2004; 63: 742-745.
9. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001; 19: 2381-2389.
10. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
11. Wallengren O, Lundholm K, Bosaeus I,. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 2013; 21: 1569-1577.
12. Fearon KC, Voss AC, Hustead DS,; Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83: 1345-1350.
13. Couch M, Lai V, Cannon T, et al. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 2007; 29: 401-411.
14. Tsai S,. Importance of lean body mass in the oncologic patient. Nutr Clin Pract 2012; 27: 593-598.
15. Chasen MR, Bhargava R,. A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Support Care Cancer 2009; 17: 1345-1351.
16. Jager-Wittenaar H, Dijkstra PU, Vissink A, et al. Changes in nutritional status and dietary intake during and after head and neck cancer treatment. Head Neck 2011; 33: 863-870.
17. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997; 19: 567-575.
18. Mick R, Vokes EE, Weichselbaum RR, Panje WR,. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg 1991; 105: 62-73.
19. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol 2005; 23: 3008-3015.
20. Rahman M, Shad F, Smith MC,. Acute kidney injury: a guide to diagnosis and management. Am Fam Physician 2012; 86: 631-639.
21. Madias NE, Harrington JT,. Platinum nephrotoxicity. Am J Med 1978; 65: 307-314.
22. Berk L, Rana S,. Hypovolemia and dehydration in the oncology patient. J Support Oncol 2006; 4: 447-454; discussion 455-457.
23. Going SB, Massett MP, Hall MC, et al. Detection of small changes in body composition by dual-energy x-ray absorptiometry. Am J Clin Nutr 1993; 57: 845-850.
24. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE,. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997-1006.
25. Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R,. Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One 2012; 7: e29330.
26. Locher JL, Bonner JA, Carroll WR, et al. Gastrostomy tube placement and use in patients with head and neck cancer. Head Neck 2012; 34: 422-428.
27. Murphy BA, Chen A, Curran WJ Jr, et al. Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. Support Care Cancer 2009; 17: 1393-1401.
28. Al-Majid S, Waters H,. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs 2008; 10: 7-20.
29. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653-1659.
30. Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O,. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012; 8: CD008465.
31. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007; 25: 4396-4404.
32. Galvão DA, Nosaka K, Taaffe DR, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 2006; 38: 2045-2052.
33. Garg S, Yoo J, Winquist E,. Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. Support Care Cancer 2010; 18: 667-677.
34. Rabinovitch R, Grant B, Berkey BA, et al. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck 2006; 28: 287-296.